Rybelsus® reduces cardiovascular events in adults with type 2 diabetes and cardiovascular or chronic kidney disease

By Editor

4th April 2025

Cardiovascular disease, Chronic Kidney Disease Pharmaceutical Pharmacy Research Type 2 diabetes